Alexion facing criminal FCPA probe
The US Department of Justice is investigating US pharmaceuticals business Alexion for potential FCPA breaches, according to a securities filing disclosed by the company on 3 November.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Subscribe now